US Pharma MarketingHigh-level turnover has introduced uncertainty about how quickly the FDA’s agency-wide AI strategy will move forward.
The FDA was all in on AI. Will that change?
The FDA was all in on AI. Will that change? is a pharma and life sciences industry update from MedTech Dive. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Source: MedTech Dive